References
- Centers for Disease Control and Prevention (CDC). Technical report 2: multi-national monkeypox outbreak, United States; 2022. https://www.cdc.gov/poxvirus/monkeypox/cases-data/technical-report/report-2.html#global. Accessed November 8, 2022.
- Ly-Yang F, Miranda-Sánchez A, Burgos-Blasco B, et al. Conjunctivitis in an individual with monkeypox. JAMA Ophthalmol. 2022;140(10):1022. doi:10.1001/jamaophthalmol.2022.3743.
- Hughes C, McCollum A, Pukuta E, et al. Ocular complications associated with acute monkeypox virus infection, DRC. Int J Infect Dis. 2014;21:276–277. doi:10.1016/j.ijid.2014.03.994.
- Kaufman AR, Chodosh J, Pineda R. Monkeypox virus and ophthalmology—a primer on the 2022 monkeypox outbreak and monkeypox-related ophthalmic disease. JAMA Ophthalmol. 2022. doi:10.1001/jamaophthalmol.2022.4567.
- Kontos G, Micheletti E. A dome-shaped eyelid nodule in a Young White Man. JAMA Ophthalmol. 2022;140(10):1011. doi:10.1001/jamaophthalmol.2022.3741.
- Foos W, Wroblewski K, Ittoop S. Subconjunctival nodule in a patient with acute monkeypox. JAMA Ophthalmol. 2022;140(10):e223742. doi:10.1001/jamaophthalmol.2022.3742.
- Lobo A-M, Agelidis AM, Shukla D. Pathogenesis of herpes simplex keratitis: the host cell response and ocular surface sequelae to infection and inflammation. Ocul Surf. 2019;17(1):40–49. doi:10.1016/j.jtos.2018.10.002.
- Smith JA. The ocular complications of smallpox and smallpox immunization. Arch Ophthalmol. 2004;122(9):1407. doi:10.1001/archopht.122.9.1407-a.
- Centers for Disease Control and Prevention (CDC). Guidance for tecovirimat use under expanded access investigational new drug protocol during 2022. U.S. Monkeypox outbreak. September, 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/Tecovirimat.html#anchor_1654624161405. Accessed November 8, 2022.